+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Polycythemia Vera - Market Insight, Epidemiology, and Market Forecast - 2036 - Product Thumbnail Image

Polycythemia Vera - Market Insight, Epidemiology, and Market Forecast - 2036

  • Report
  • April 2026
  • 256 Pages
  • Global
From
Diabetic Peripheral Neuropathy - Pipeline Insight, 2026 - Product Thumbnail Image

Diabetic Peripheral Neuropathy - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 180 Pages
  • Global
From
Chronic Kidney Disease - Competitive Landscape and Clinical Trial Analysis, 2026 - Product Thumbnail Image

Chronic Kidney Disease - Competitive Landscape and Clinical Trial Analysis, 2026

  • Report
  • September 2026
  • 280 Pages
  • Global
From
Chronic Kidney Disease - Market Insight, Epidemiology, and Market Forecast - 2036 - Product Thumbnail Image

Chronic Kidney Disease - Market Insight, Epidemiology, and Market Forecast - 2036

  • Report
  • September 2026
  • 200 Pages
  • Global
From
Diabetes Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Thumbnail Image

Diabetes Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Drug Pipelines
  • September 2026
  • 150 Pages
  • Global
From
Type 2 Diabetes - Market Insight, Epidemiology, and Market Forecast - 2036 - Product Thumbnail Image

Type 2 Diabetes - Market Insight, Epidemiology, and Market Forecast - 2036

  • Report
  • September 2026
  • 200 Pages
  • Global
From
Obesity - Competitive Landscape and Clinical Trial Analysis, 2026 - Product Thumbnail Image

Obesity - Competitive Landscape and Clinical Trial Analysis, 2026

  • Report
  • September 2026
  • 450 Pages
  • Global
From
Alzheimer's Disease - Competitive Landscape and Clinical Trial Analysis, 2026 - Product Thumbnail Image

Alzheimer's Disease - Competitive Landscape and Clinical Trial Analysis, 2026

  • Report
  • September 2026
  • 450 Pages
  • Global
From
Chronic Pain - Market Insight, Epidemiology, and Market Forecast - 2036 - Product Thumbnail Image

Chronic Pain - Market Insight, Epidemiology, and Market Forecast - 2036

  • Report
  • September 2026
  • 200 Pages
  • Global
From
Chronic Lower Back Pain - Market Insight, Epidemiology, and Market Forecast - 2036 - Product Thumbnail Image

Chronic Lower Back Pain - Market Insight, Epidemiology, and Market Forecast - 2036

  • Report
  • September 2026
  • 200 Pages
  • Global
From
Anti-Obesity Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Thumbnail Image

Anti-Obesity Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Drug Pipelines
  • September 2026
  • 150 Pages
  • Global
From
Glucagon-Like Peptide-1 (GLP-1) Agonists - Market Size, Target Population, Competitive Landscape & Market Forecast - 2036 - Product Thumbnail Image

Glucagon-Like Peptide-1 (GLP-1) Agonists - Market Size, Target Population, Competitive Landscape & Market Forecast - 2036

  • Report
  • September 2026
  • 120 Pages
  • Global
From
Type 2 Diabetes - Competitive Landscape and Clinical Trial Analysis, 2026 - Product Thumbnail Image

Type 2 Diabetes - Competitive Landscape and Clinical Trial Analysis, 2026

  • Report
  • September 2026
  • 450 Pages
  • Global
From
Obstructive Sleep Apnea - Competitive Landscape and Clinical Trial Analysis, 2026 - Product Thumbnail Image

Obstructive Sleep Apnea - Competitive Landscape and Clinical Trial Analysis, 2026

  • Report
  • September 2026
  • 180 Pages
  • Global
From
Type 2 Diabetes Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Thumbnail Image

Type 2 Diabetes Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Drug Pipelines
  • September 2026
  • 150 Pages
  • Global
From
Interleukin-17 (IL-17) Inhibitors - Target Population, Competitive Landscape, and Market Forecast - 2036 - Product Thumbnail Image

Interleukin-17 (IL-17) Inhibitors - Target Population, Competitive Landscape, and Market Forecast - 2036

  • Report
  • September 2026
  • 120 Pages
  • Global
From
LUXTURNA Sales Forecast, and Market Size Analysis - 2034 - Product Thumbnail Image

LUXTURNA Sales Forecast, and Market Size Analysis - 2034

  • Report
  • August 2026
  • 30 Pages
  • Global
From
EYLEA Sales Forecast, and Market Size Analysis - 2034 - Product Thumbnail Image

EYLEA Sales Forecast, and Market Size Analysis - 2034

  • Report
  • August 2026
  • 30 Pages
  • Global
From
OLUMIANT Sales Forecast, and Market Size Analysis - 2034 - Product Thumbnail Image

OLUMIANT Sales Forecast, and Market Size Analysis - 2034

  • Report
  • August 2026
  • 30 Pages
  • Global
From
Central Nervous System (CNS) Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Thumbnail Image

Central Nervous System (CNS) Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • August 2026
  • 150 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more